With 1.52 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.13 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.01 whereas the lowest price it dropped to was $0.85. The 52-week range on BCTX shows that it touched its highest point at $5.97 and its lowest point at $0.46 during that stretch. It currently has a 1-year price target of $15.00. Beta for the stock currently stands at 1.42.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BCTX was up-trending over the past week, with a rise of 24.51%, but this was up by 27.60% over a month. Three-month performance surged to 24.73% while six-month performance fell -41.87%. The stock lost -80.81% in the past year, while it has lost -83.21% so far this year. A look at the trailing 12-month EPS for BCTX yields -1.16 with Next year EPS estimates of -0.39. For the next quarter, that number is -0.30. This implies an EPS growth rate of 7.41% for this year and 61.00% for next year.
Float and Shares Shorts:
At present, 36.18 million BCTX shares are outstanding with a float of 32.50 million shares on hand for trading. On 2024-11-15, short shares totaled 0.53 million, which was 148.0 higher than short shares on 1728950400. In addition to Dr. William V. Williams M.D. as the firm’s CEO, President & Director, Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. serves as its CFO & Corporate Secretary.
Institutional Ownership:
Through their ownership of 0.056760002 of BCTX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-07-31, BCTX reported revenue of $0.0 and operating income of -$5767954.0. The EBITDA in the recently reported quarter was -$10265878.0 and diluted EPS was $nan.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With BCTX analysts setting a high price target of 15.0 and a low target of 15.0, the average target price over the next 12 months is 15.0. Based on these targets, BCTX could surge 1430.61% to reach the target high and rise by 1430.61% to reach the target low. Reaching the average price target will result in a growth of 1430.61% from current levels.
Analysts have provided yearly estimates in a range of -$1.09066 being high and -$1.09066 being low. For BCTX, this leads to a yearly average estimate of -$1.09066.
